Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia

Katja Seipel1, Miguel Teixera Marques2, Marie-Ange Bozzini2

  • 1Department of Clinical Research, University and University Hospital of Berne, Berne, Switzerland. Department of Medical Oncology, University and University Hospital of Berne, Berne, Switzerland.

Abstract

Insights

The p53-KLF4-CEBPA axis is disrupted in acute myeloid leukemia (AML). Restoring p53 function via chemotherapy or novel treatments reactivates this axis, promoting myeloid differentiation and cell-cycle arrest in AML cells.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myeloid leukemia (AML) is characterized by frequent deregulation of key transcription factors and tumor suppressors.
  • CEBPA, KLF4, and p53 play critical roles in normal hematopoiesis and are often dysregulated in AML.

Purpose of the Study:

  • To investigate the extent of CEBPA, KLF4, and p53 dysregulation in AML.
  • To elucidate the molecular interactions and mechanisms underlying this deregulation.
  • To explore the potential for therapeutic restoration of the p53-KLF4-CEBPA axis.

Main Methods:

  • Analysis of protein levels of CEBPA, KLF4, p53, and their modulators in 110 AML patient samples.
  • Characterization of CEBPA gene expression regulation by KLF4 and p53 in AML cell lines.
  • Assessment of p53 function restoration using chemotherapy and p53-activating agents.

Main Results:

  • A direct regulatory axis (p53-KLF4-CEBPA) was identified, where p53 and KLF4 activate CEBPA transcription.
  • AML patient cells exhibited loss of p53 function, reduced KLF4 and CEBPA protein levels, and elevated levels of p53 inhibitors (MDM2, CUL9/PARC) and nuclear export protein (XPO1/CRM1).
  • Restoration of p53 function induced CEBPA expression, myeloid differentiation, and cell-cycle arrest in AML cells.

Conclusions:

  • The p53-KLF4-CEBPA axis is significantly deregulated in AML.
  • Therapeutic strategies targeting p53 restoration, including conventional chemotherapy and novel p53-activating treatments, can reactivate this axis.
  • Restoring the p53-KLF4-CEBPA axis holds promise for AML treatment by inducing differentiation and cell-cycle arrest.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K